AlphaFold predicted structure
LSR · Q86X29

Mean pLDDT
57.4/ 100
Low
649 residues
Confidence breakdown
- Very high(≥ 90)14%
- Confident(70–90)16%
- Low(50–70)17%
- Very low(< 50)52%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
lipolysis stimulated lipoprotein receptor
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Cholestasis
BIALLELIC, autosomal or pseudoautosomalneurodegenerative disease
progressive familial intrahepatic cholestasis
progressive familial intrahepatic cholestasis type 1
Intellectual disability
Short stature
short stature due to GHSR deficiency
lysosomal storage disease
endometrial cancer
lung adenocarcinoma
neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Lipolysis-stimulated lipoprotein receptor
Probable role in the clearance of triglyceride-rich lipoprotein from blood. Binds chylomicrons, LDL and VLDL in presence of free fatty acids and allows their subsequent uptake in the cells (By similarity). Maintains epithelial barrier function by recruiting MARVELD2/tricellulin to tricellular tight junctions (By similarity)
LSR · Q86X29

Mean pLDDT
57.4/ 100
Low
649 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0